Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03210831

Early Predictors of Necrotizing Enterocolitis in Neonates

Clinical Model for Early Predictors of Necrotizing Enterocolitis in Neonates

Status
Recruiting
Phase
Study type
Observational
Enrollment
450 (estimated)
Sponsor
Nationwide Children's Hospital · Academic / Other
Sex
All
Age
7 Days
Healthy volunteers
Accepted

Summary

The goal of this project is to identify neonates who are predisposed to Necrotizing Enterocolitis (NEC). the investigators will determine the effectiveness of non-invasive measures as well as biochemical markers to identify neonates early in the disease process. Thus, the investigators aim to identify infants with NEC prior to the onset of symptoms to institute or test treatments in the long term to prevent the progression of the disease in these infants.

Detailed description

The study will enroll premature, low birth weight infants in the Neonatal Intensive Care Units (NICU). Potential study subjects will be identified upon delivery, or transfer to the NICU, and notification by the neonatology service. Infants born at less than 30 weeks gestational age, birth weight less than or equal to 1500 grams will be eligible for enrollment in the study. The purpose of the study designed is to compare the splanchnic tissue oxygenation index and gut inflammatory biomarkers of patients with any stage of NEC with healthy controls. Since we will not be able to determine which patients will develop NEC a priori, we will anticipate enrolling up to 450 neonates to identify 15 neonates with NEC.

Conditions

Timeline

Start date
2017-09-06
Primary completion
2026-06-01
Completion
2026-12-01
First posted
2017-07-07
Last updated
2025-06-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03210831. Inclusion in this directory is not an endorsement.

Early Predictors of Necrotizing Enterocolitis in Neonates (NCT03210831) · Clinical Trials Directory